Background: Previous research has demonstrated that the psychological morbidity experienced by informal caregivers is associated with increased vulnerability to infectious diseases, in particular influenza. A pragmatic trial was conducted to examine whether a stress management intervention (SMI) could reduce psychological morbidity and enhance the antibody response to influenza vaccination in the elderly, and whether changes in immune response of SMI participants were associated with hypothalamic-pituitary-adrenal (HPA) axis activity. Methods: Forty-three elderly spousal carers of dementia patients and 27 non-carer controls were recruited. Sixteen carers were allocated to an 8-week SMI or a non-intervention condition (n = 27). The non-carers formed a no treatment, ‘normal’ comparison group. At the end of the SMI or its equivalent time period, all participants received an influenza vaccination. IgG antibody titres to the vaccine were measured 0, 2, 4 and 6 weeks post-vaccine. Results: There was evidence of elevated distress in both carer groups compared with non-carer controls throughout the SMI period, but no between-group differences in salivary cortisol. Immune responses to the vaccine revealed that 50% of SMI carers, 7% of non-intervention carers and 29% of non-carer controls produced a four-fold increase in antibody titre. Conclusions: The immune response to influenza vaccination appears amenable to improvement through stress management, although the mechanisms underlying this effect remain unclear.

Keywords:
Stress, Influenza, Elderly, Immunity, Antibody titres, Psychoneuroimmunology, Cortisol, HPA axis
1.
Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, D’Agostino RB: Lifetime risk of dementia and Alzheimer’s disease: The impact of mortality on risk estimates in the Framingham Study. Neurology 1997;49:498–1504.
2.
Haan MN, Selby JV, Rice DP, Quesenberry CP Jr, Schofield KA, Liu J, Fireman BH: Trends in cardiovascular disease incidence and survival in the elderly. Ann Epidemiol 1996;6:348–356.
3.
Klontz KC, Adler WH, Potter M: Age-dependent resistance factors in the pathogenesis of foodborne infectious disease. Aging (Milano) 1997;9:320–326.
4.
Ackerman KD, Martino M, Heyman R, Moyna NM, Rabin BS: Immunologic response to acute psychological stress in MS patients and controls. J Neuroimmunol 1996;68:85–94.
5.
Glaser R, Kiecolt-Glaser JK: Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1. Ann Behav Med 1997;19:78–82.
6.
Yang EV, Glaser R: Stress-induced immunomodulation: Impact on immune defences against infectious disease. Biomed Pharmacother 2000;54:245–250.
7.
Biondi M, Zannino LG: Psychological stress, neuroimmunomodulation, and susceptibility to infectious diseases in animals and man: A review. Psychother Psychosom 1997;66:3–26.
8.
Cobb JMT, Steptoe A: Psychosocial stress and susceptibility to upper respiratory tract illness in an adult population sample. Psychosom Med 1996;58:404–412.
9.
Cohen S, Miller GE: Stress, immunity and susceptibility to upper respiratory infection; in Psychoneuroimmunology, ed 3. San Diego, Academic Press, 2001, pp 499–509.
10.
Chen S, Doyle WJ, Skoner DP: Psychological stress, cytokine production and severity of upper respiratory illness. Psychosom Med 1999;61:175–180.
11.
Wallsten SM: Comparing patterns of stress in daily experiences of elderly caregivers and non-caregivers. Int J Aging Hum Dev 1993, 37:55–68.
12.
Murray JM, Manela MV, Shuttleworth A, Livingston GA: Caring for an older spouse with a psychiatric illness. Aging Ment Health 1997;1:256–260.
13.
Castle S, Wilkins S, Heck E, Tanzy K, Fahey J: Depression in caregivers of demented patients is associated with altered immunity-impaired proliferative capacity, increased CD8+ and a decline in lymphocytes with surface signal-transduction molecules (CD38+) and a cytotoxicity marker (CD56+ CD8+). Clin Exp Immunol 1995;101:487–493.
14.
Kiecolt-Glaser JK, Glaser R, Shuttleworth EC, Dyer CS, Ogrocki P, Speicher CE: Chronic stress and immunity in family caregivers of Alzheimer’s disease victims. Psychosom Med 1987;49:523–535.
15.
Esterling BA, Kiecolt-Glaser JK, Glaser R: Psychosocial modulation of cytokine induced natural killer cell activity in older adults. Psychosom Med 1996;58:264–272.
16.
Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey WB, Sheridan J: Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci USA 1996;93:3043–3047.
17.
Patriarca PA: A randomized controlled trial of influenza vaccine in the elderly: Scientific scrutiny and ethical responsibility. JAMA 1994;272:1700–1701.
18.
Vedhara K, Cox NKM, Wilcock GK, Perks P, Hunt M, Anderson S, Lightman SL, Shanks NM: Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 1999;353:627–631.
19.
DeFeo P, Perriello G, Torlone E, Ventura MM, Fanelli C, Santeusanio F, Brunetti P, Gerich JE, Bolli GB: Contribution of cortisol to glucose counterregulation in humans. Am J Physiol 1989;257:E35–E42.
20.
Kirschbaum C, Prussner JC, Stone AA, Federenko I, Gaab J, Lintz D, Schommer N, Hellhammer DH: Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom Med 1995;57:468–474.
21.
Hiemke C, Brunner R, Hammes E, Muller H, Zumuschenfelde KHM, Lohse AW: Circadian variations in antigen-specific proliferation of human T-lymphocytes and correlation to cortisol production. Psychoneuroendocrinology 1995;20:335–342.
22.
Antoni MH, Cruess S, Cruess DG, Kumar, M: Cognitive-behavioural stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann Behav Med 2000;22:29–37.
23.
Cruess DG, Antoni MH, Kumar M, Schneiderman N: Reductions in salivary cortisol are associated with mood improvement during relaxation training among HIV seropositive men. J Behav Med 2000;23:107–122.
24.
Pearlin LI, Mullan JT, Semple SJ, Skaff MM: Caregiving and the stress process: An overview of concepts and their measures. Gerontologist 1990;30:583–594.
25.
Brodaty H, Gresham M. Effect of a training programme to reduce stress in carers of patients with dementia. Br Med J 1989;299:1375–1379.
26.
Brodaty H, Gresham M, Luscombe G: The Prince Henry Hospital dementia caregivers’ training programme. Int J Geriatr Psychiatry 1997;12:183–192.
27.
Egan G: The Skilled Helper. A Problem-Management Approach to Helping. Pacific Grove, Brooks/Cole Publishing, 1998.
28.
Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–370.
29.
Cohen S, Kamarack T, Mermelstein R: A global measure of perceived stress. J Health Soc Behav 1983;24:385–396.
30.
Zarit SH, Zarit JM: Cognitive impairment of older people: Etiology, evaluation and interventions; in Lewinsohn PM, Teri L (eds): Coping and Adaptation in the Elderly. New York, Pergamon Press, 1983.
31.
Shimada M, Takahashi K, Ohkawa T, Segawa M, Higurashi M: Determination of salivary cortisol by ELISA and its application to the assessment of the circadian rhythm in children. Horm Res 1995;44:213–217.
32.
Schwartz CE, Sprangers MAG: Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med 1999;48:1531–1548.
33.
Lacey K, Zaharia MD, Griffiths J, Ravindran AV, Merali Z, Anisman H: A prospective study of neuroendocrine and immune alterations associated with the stress of an oral academic examination among graduate students. Psychoneuroendocrinology 2000;25:339–356.
34.
Peters ML, Godaert GLR, Ballieux RE, Brosschot JF, Sweep FCGJ, Swinkels LMJW, van Vliet M, Heijnen CJ: Immune responses to experimental stress: Effects of mental effort and uncontrollability. Psychosom Med 1999;61:513–524.
35.
Schmidt-Reinwald A, Pruessner JC, Hellhammer DH, Federenko I, Rohleder N, Schurmeyer TH, Kirschbaum C: The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. Life Sci 1999;64:1653–1660.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.